These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 34293749)

  • 21. Persistent phosphaturic mesenchymal tumor causing tumor-induced osteomalacia treated with image-guided ablation.
    Horng JC; Van Eperen E; Tutton S; Singh R; Shaker JL; Wooldridge AN
    Osteoporos Int; 2021 Sep; 32(9):1895-1898. PubMed ID: 33655402
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Tumour-induced osteomalacia: a literature review and a case report.
    Dadoniene J; Miglinas M; Miltiniene D; Vajauskas D; Seinin D; Butenas P; Kacergius T
    World J Surg Oncol; 2016 Jan; 14(1):4. PubMed ID: 26744291
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Tumor-induced osteomalacia - a mystery illness beyond aches, pains, and depression.
    Ni HJ; Clifton-Bligh R; Brzozowska MM
    Endocr Regul; 2021 Sep; 55(3):163-168. PubMed ID: 34523297
    [No Abstract]   [Full Text] [Related]  

  • 24. Fibroblast Growth Factor 23-Induced Hypophosphatemia in Acute Leukemia.
    Reinert RB; Bixby D; Koenig RJ
    J Endocr Soc; 2018 May; 2(5):437-443. PubMed ID: 29696242
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tumour-induced osteomalacia: An emergent paraneoplastic syndrome.
    Alonso G; Varsavsky M
    Endocrinol Nutr; 2016 Apr; 63(4):181-6. PubMed ID: 26718193
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hypophosphatemia and FGF23 tumor-induced osteomalacia in two cases of metastatic breast cancer.
    Abramson M; Glezerman IG; Srinivasan M; Ross R; Flombaum C; Gutgarts V
    Clin Nephrol; 2021 Feb; 95(2):104-111. PubMed ID: 33191899
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Tumor-induced osteomalacia.
    Fukumoto S
    Panminerva Med; 2024 Jun; 66(2):188-197. PubMed ID: 38127062
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Diagnostic utility of magnetic resonance imaging skeletal survey in a patient with oncogenic osteomalacia.
    Fukumoto S; Takeuchi Y; Nagano A; Fujita T
    Bone; 1999 Sep; 25(3):375-7. PubMed ID: 10495143
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Tumor-induced osteomalacia associated with a maxillofacial tumor producing fibroblast growth factor 23: report of a case and review of the literature.
    Mori Y; Ogasawara T; Motoi T; Shimizu Y; Chikazu D; Tamura K; Fukumoto S; Takato T
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2010 Mar; 109(3):e57-63. PubMed ID: 20219587
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ameloblastic Fibroodontoma of Mandible Causing Tumor Induced Osteomalacia: A Case Report with Review of 88 Phosphaturic Oral Neoplasms.
    Mishra D; Kaur H; Bhalla AS; Manchanda S; Sasikumar J; Agarwal B; Roychoudhury A
    Head Neck Pathol; 2021 Sep; 15(3):975-988. PubMed ID: 33394371
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Tumor-induced osteomalacia with elevated fibroblast growth factor 23: a case of phosphaturic mesenchymal tumor mixed with connective tissue variants and review of the literature.
    Hu FK; Yuan F; Jiang CY; Lv DW; Mao BB; Zhang Q; Yuan ZQ; Wang Y
    Chin J Cancer; 2011 Nov; 30(11):794-804. PubMed ID: 22035861
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Renal Phosphate Wasting Due to Tumor-Induced (Oncogenic) Osteomalacia.
    Amaratunga EA; Ernst EB; Kamau J; Kotala R; Snyder R
    Cureus; 2021 Jun; 13(6):e15507. PubMed ID: 34268038
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Tumour-induced osteomalacia: a rare cause of chronic pain and weakness.
    Nasr JT; Tohme J; Collins MT; Drake MT; Hartley IR; Sfeir J; Dockery K; Taskin M
    Pract Neurol; 2022 Dec; 22(6):528-531. PubMed ID: 35896375
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Acquired hypophosphatemic osteomalacia associated with multiple myeloma.
    Narvaez J; Domingo-Domenech E; Narvaez JA; Nolla JM; Valverde J
    Joint Bone Spine; 2005 Oct; 72(5):424-6. PubMed ID: 16112595
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hypophosphatemia related to paraneoplastic Cushing syndrome in prostate cancer: cure after bilateral adrenalectomy.
    Ramon I; Kleynen P; Valsamis J; Body JJ; Karmali R
    Calcif Tissue Int; 2011 Dec; 89(6):442-5. PubMed ID: 21910004
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ovarian cancer-related hypophosphatemic osteomalacia--a case report.
    Lin HA; Shih SR; Tseng YT; Chen CH; Chiu WY; Hsu CY; Tsai KS
    J Clin Endocrinol Metab; 2014 Dec; 99(12):4403-7. PubMed ID: 25181387
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Burosumab in tumor-induced osteomalacia: A case report.
    Day AL; Gutiérrez OM; Guthrie BL; Saag KG
    Joint Bone Spine; 2020 Jan; 87(1):81-83. PubMed ID: 31382017
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hypophosphaturic mesenchymal tumor of the ethmoid associated with oncogenic osteomalacia.
    Ungari C; Rocchi G; Rinna C; Agrillo A; Lattanzi A; Pagnoni M
    J Craniofac Surg; 2004 May; 15(3):523-7. PubMed ID: 15111823
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Oncogenic osteomalacia: two case reports with surprisingly different outcomes.
    Seijas R; Ares O; Sierra J; Pérez-Dominguez M
    Arch Orthop Trauma Surg; 2009 Apr; 129(4):533-9. PubMed ID: 19125258
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Tumor-Induced Osteomalacia Caused by a Phosphaturic Mesenchymal Tumor of the Sole Presenting as a Crippling Illness in a Postmenopausal Woman.
    Fang X; Zhang W; Yu Z; Liu H; Xiong Y; Luo Y; Song L; Li J; Duan H
    J Foot Ankle Surg; 2020; 59(5):1113-1117. PubMed ID: 32622675
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.